Anticorps Monoclonal anti-Polyglutamine

Polyglutamine Monoclonal Antibody for WB

Hôte / Isotype

Mouse / IgG2b, kappa

Réactivité testée

Applications

WB

Conjugaison

Non conjugué

CloneNo.

MW1

N° de cat : 65239-1-Ig

Synonymes

Glutamine repeats, HTT, Huntington disease protein, Polyglutamine, polyQ



Applications testées

Résultats positifs en WBProtéine recombinante

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB :
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

65239-1-Ig cible Polyglutamine dans les applications de WB et montre une réactivité avec des échantillons

Réactivité
Hôte / Isotype Mouse / IgG2b, kappa
Clonalité Monoclonal
Type Anticorps
Immunogène Protéine recombinante
Nom complet Polyglutamine
Numéro d’acquisition GenBankN/A
Symbole du gène
Identification du gène (NCBI)
Conjugaison Non conjugué
Forme Liquide
Méthode de purification N/A
Tampon de stockage PBS with 0.09% sodium azide.
Conditions de stockageStore at 2-8°C. Stable for one year after shipment. 20ul contiennent 0,1% de BSA.

Informations générales

Huntington's disease is a neurodegenerative disorder caused by the expansion of a polyglutamine (polyQ) repeat in the N-terminal portion of huntingtin protein to a length above 35-40 units (PMID: 26047735; 19507258). The mutational expansion of polyglutamine above a critical length causes a toxic gain of function in huntingtin and results in neuronal death. In the course of the disease, expanded huntingtin is proteolyzed, becomes abnormally folded, and accumulates in oligomers, fibrils, and microscopic inclusions (PMID: 25336039). The anti-polyglutamine (polyQ) antibody MW1 specifically binds the polyQ domain of huntingtin exon 1. On western blot, the MW1 clone strongly prefers to bind to the expanded polyQ repeat form of Htt, displaying no detectable binding to normal huntingtin (PMID: 11719267).